Brain Pathology

Papers
(The median citation count of Brain Pathology is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
The 2021 WHO Classification of Tumors of the Central Nervous System: An update on pediatric low‐grade gliomas and glioneuronal tumors105
COVID‐19‐related neuropathology and microglial activation in elderly with and without dementia81
SARS‐CoV‐2 and the brain: A review of the current knowledge on neuropathology in COVID‐1977
Classification of adult‐type diffuse gliomas: Impact of the World Health Organization 2021 update69
The microbiota–microglia axis in central nervous system disorders62
Brain ischemic injury in COVID‐19‐infected patients: a series of 10 post‐mortem cases58
The role of interferons type I, II and III in myositis: A review56
Microglia activation in postmortem brains with schizophrenia demonstrates distinct morphological changes between brain regions56
Chronic sleep deprivation altered the expression of circadian clock genes and aggravated Alzheimer's disease neuropathology52
Mediators of cerebral hypoperfusion and blood‐brain barrier leakiness in Alzheimer’s disease, vascular dementia and mixed dementia51
Intracranial mesenchymal tumor with FET‐CREB fusion—A unifying diagnosis for the spectrum of intracranial myxoid mesenchymal tumors and angiomatoid fibrous histiocytoma‐like neoplasms48
Pathological changes within the cerebral vasculature in Alzheimer’s disease: New perspectives46
Accumulation of neurofibrillary tangles and activated microglia is associated with lower neuron densities in the aphasic variant of Alzheimer’s disease40
Dysregulated protein phosphorylation: A determining condition in the continuum of brain aging and Alzheimer's disease38
Updates in the classification of ependymal neoplasms: The 2021 WHO Classification and beyond38
MRI and muscle imaging for idiopathic inflammatory myopathies38
Glycocalyx is critical for blood‐brain barrier integrity by suppressing caveolin1‐dependent endothelial transcytosis following ischemic stroke37
Interaction of microglia with infiltrating immune cells in the different phases of stroke36
Tumor cell and immune cell profiles in primary human glioblastoma: Impact on patient outcome35
The spectrum of rare central nervous system (CNS) tumors with EWSR1‐non‐ETS fusions: experience from three pediatric institutions with review of the literature33
Prognostic impact of genetic alterations and methylation classes in meningioma32
TREM2‐induced activation of microglia contributes to synaptic integrity in cognitively intact aged individuals with Alzheimer's neuropathology29
Infective myositis29
Limbic‐predominant age‐related TDP‐43 encephalopathy neuropathologic change and microvascular pathologies in community‐dwelling older persons28
Glutamatergic receptor expression changes in the Alzheimer's disease hippocampus and entorhinal cortex28
Evaluating the performance of large language models: ChatGPT and Google Bard in generating differential diagnoses in clinicopathological conferences of neurodegenerative disorders26
Toward a refined genotype–phenotype classification scheme for the international consensus classification of Focal Cortical Dysplasia26
Postmortem neuropathology in COVID‐1925
Hypothesis review: Alzheimer's overture guidelines25
Ependymoma‐like tumor with mesenchymal differentiation harboring C11orf95NCOA1/2 or ‐RELA fusion: A hitherto unclassified tumor related to ependymoma24
Detection and quantification of novel C‐terminal TDP‐43 fragments in ALS‐TDP24
Isoform‐specific upregulation of FynT kinase expression is associated with tauopathy and glial activation in Alzheimer's disease and Lewy body dementias23
The use and limitations of single‐cell mass cytometry for studying human microglia function23
A deep learning‐based model for prediction of hemorrhagic transformation after stroke21
Mitochondrial DNA variants in inclusion body myositis characterized by deep sequencing21
Accumulation of cellular prion protein within β‐amyloid oligomer plaques in aged human brains20
Effect of olfactory bulb pathology on olfactory function in normal aging19
Histopathological patterns in atypical teratoid/rhabdoid tumors are related to molecular subgroup19
Proteomic analysis of human hippocampal subfields provides new insights into the pathogenesis of Alzheimer’s disease and the role of glial cells19
Diverse changes in microglia morphology and axonal pathology during the course of 1 year after mild traumatic brain injury in pigs18
Aged Tmem106b knockout mice display gait deficits in coincidence with Purkinje cell loss and only limited signs of non‐motor dysfunction18
The fate of interneurons, GABAA receptor sub‐types and perineuronal nets in Alzheimer's disease18
Fibrinogen in the glioblastoma microenvironment contributes to the invasiveness of brain tumor‐initiating cells18
Glial activation in prion diseases is selectively triggered by neuronal PrPSc18
Distinct circular RNA expression profiles in pediatric ependymomas18
Extralysosomal cathepsin B in central nervous system: Mechanisms and therapeutic implications18
Inflammatory features in sporadic late‐onset nemaline myopathy are independent from monoclonal gammopathy17
Identification of inflammasome signaling proteins in neurons and microglia in early and intermediate stages of Alzheimer's disease17
The epigenetic mechanisms involved in mitochondrial dysfunction: Implication for Parkinson’s disease17
Multiple system atrophy variant with severe hippocampal pathology17
Independent distribution between tauopathy secondary to subacute sclerotic panencephalitis and measles virus: An immunohistochemical analysis in autopsy cases including cases treated with aggressive a17
Contribution of the astrocytic tau pathology to synapse loss in progressive supranuclear palsy and corticobasal degeneration16
Pathological tau signatures and nuclear alterations in neurons, astrocytes and microglia in Alzheimer's disease, progressive supranuclear palsy, and dementia with Lewy bodies16
An integrative histopathological and epigenetic characterization of primary intracranial mesenchymal tumors, FET:CREB‐fused broadening the spectrum of tumor entities in comparison with their soft tiss16
The association between neurodegeneration and local complement activation in the thalamus to progressive multiple sclerosis outcome16
Reconstituting neurovascular unit with primary neural stem cells and brain microvascular endothelial cells in three‐dimensional matrix16
Cognitive decline in amyotrophic lateral sclerosis: Neuropathological substrate and genetic determinants15
Oligodendrocyte‐specific deletion of FGFR2 ameliorates MOG35‐55‐induced EAE through ERK and Akt signalling15
NanoString technology distinguishes anti‐TIF‐1γ+ from anti‐Mi‐2+ dermatomyositis patients15
Clinical implementation of integrated molecular‐morphologic risk prediction for meningioma14
Novel genetic variants in MAPT and alterations in tau phosphorylation in amyotrophic lateral sclerosis post‐mortem motor cortex and cerebrospinal fluid14
Integrated genotype–phenotype analysis of long‐term epilepsy‐associated ganglioglioma14
Molecular diagnostics in drug‐resistant focal epilepsy define new disease entities14
Inactivation of the CB2 receptor accelerated the neuropathological deterioration in TDP‐43 transgenic mice, a model of amyotrophic lateral sclerosis14
Variability in the type and layer distribution of cortical Aβ pathology in familial Alzheimer’s disease14
Muscle pathology of antisynthetase syndrome according to antibody subtypes14
Downregulated GPR30 expression in the epileptogenic foci of female patients with focal cortical dysplasia type IIb and tuberous sclerosis complex is correlated with 18F‐FDG PET‐CT values13
A novel temporal‐predominant neuro‐astroglial tauopathy associated with TMEM106B gene polymorphism in FTLD/ALS‐TDP13
Association of CD2AP neuronal deposits with Braak neurofibrillary stage in Alzheimer’s disease13
Focal cortical dysplasia type 113
Motor neuron involvement expands the neuropathological phenotype of late‐onset ataxia in RFC1 mutation (CANVAS)13
Intracranial mesenchymal tumors with FET‐CREB fusion are composed of at least two epigenetic subgroups distinct from meningioma and extracranial sarcomas13
Embryonal and non‐meningothelial mesenchymal tumors of the central nervous system – Advances in diagnosis and prognostication13
Alpha‐synuclein‐associated changes in PINK1‐PRKN‐mediated mitophagy are disease context dependent13
Molecular neuropathology of brain‐invasive meningiomas12
Region‐specific preservation of Purkinje cell morphology and motor behavior in the ATXN1[82Q] mouse model of spinocerebellar ataxia 112
Targeting the interaction of GABAB receptors with CaMKII with an interfering peptide restores receptor expression after cerebral ischemia and inhibits progressive neuronal death in mouse br12
Overexpression of the ubiquitin‐editing enzyme A20 in the brain lesions of Multiple Sclerosis patients: moving from systemic to central nervous system inflammation12
Axonal injury following mild traumatic brain injury is exacerbated by repetitive insult and is linked to the delayed attenuation of NeuN expression without concomitant neuronal death in the mouse12
Genomic profiling and prognostic factors of H3 K27M‐mutant spinal cord diffuse glioma11
Impact of α‐synuclein spreading on the nigrostriatal dopaminergic pathway depends on the onset of the pathology11
Use of advanced neuroimaging and artificial intelligence in meningiomas11
Upregulation of the pathogenic transcription factor SPI1/PU.1 in tuberous sclerosis complex and focal cortical dysplasia by oxidative stress11
Expanding the spectrum of EWSR1‐PATZ1 rearranged CNS tumors: An infantile case with leptomeningeal dissemination11
Deciphering the heterogeneity of myeloid cells during neuroinflammation in the single‐cell era11
Heterogeneity of cellular inflammatory responses in ageing white matter and relationship to Alzheimer’s and small vessel disease pathologies11
Accumulation of misfolded SOD1 outlines distinct patterns of motor neuron pathology and death during disease progression in a SOD1G93A mouse model of amyotrophic later10
CNS inflammation after natalizumab therapy for multiple sclerosis: A retrospective histopathological and CSF cohort study10
Monomeric C‐reactive protein: A novel biomarker predicting neurodegenerative disease and vascular dysfunction10
Serotonin transporter in the temporal lobe, hippocampus and amygdala in SUDEP10
Molecular landscape of IDH‐wild type, pTERT‐wild type adult glioblastomas10
Endoplasmic reticulum‐stress and unfolded protein response‐activation in immune‐mediated necrotizing myopathy9
Deficiency of Tet3 in nucleus accumbens enhances fear generalization and anxiety‐like behaviors in mice9
TDP‐43 and tau concurrence in the entorhinal subfields in primary age‐related tauopathy and preclinical Alzheimer's disease9
IDH‐mutant brainstem gliomas in adolescent and young adult patients: Report of three cases and review of the literature9
Automated and unbiased discrimination of ALS from control tissue at single cell resolution9
The neurovasculature as a target in temporal lobe epilepsy9
Postmortem quantitative MRI disentangles histological lesion types in multiple sclerosis9
Brain‐specific loss of Abcg1 disturbs cholesterol metabolism and aggravates pyroptosis and neurological deficits after traumatic brain injury9
Loss of Tmem106b leads to cerebellum Purkinje cell death and motor deficits9
Does etiology really matter for epilepsy surgery outcome?9
Alleviation of extensive visual pathway dysfunction by a remyelinating drug in a chronic mouse model of multiple sclerosis9
Application of deep learning to understand resilience to Alzheimer's disease pathology8
Alpha‐synuclein fibrils amplified from multiple system atrophy and Parkinson's disease patient brain spread after intracerebral injection into mouse brain8
Application of single cell genomics to focal epilepsies: A call to action8
lncRNA MEG3 restrained the M1 polarization of microglia in acute spinal cord injury through the HuR/A20/NF‐κB axis8
The influence of HLA‐DRB1*15 on the relationship between microglia and neurons in multiple sclerosis normal appearing cortical grey matter8
Ermin deficiency leads to compromised myelin, inflammatory milieu, and susceptibility to demyelinating insult8
Aβ plaques do not protect against HSV‐1 infection in a mouse model of familial Alzheimer's disease, and HSV‐1 does not induce Aβ pathology in a model of late onset Alzheimer's di8
Prognostic relevance of adding MRI data to WHO 2016 and cIMPACT‐NOW updates for diffuse astrocytic tumors in adults. Working toward the extended use of MRI data in integrated glioma diagnosis8
LAMP‐2A ablation in hippocampal CA1 astrocytes confers cerebroprotection and ameliorates neuronal injury after global brain ischemia7
Myxoid glioneuronal tumor, PDGFRA p.K385L‐mutant, arising in midbrain tectum with multifocal CSF dissemination7
CHCHD2 p.Thr61Ile knock‐in mice exhibit motor defects and neuropathological features of Parkinson's disease7
Old age amyotrophic lateral sclerosis and limbic TDP‐43 pathology7
ZFTA‐YAP1 fusion‐positive ependymoma can occur in the spinal cord: Letter to the editor7
Reduction in miR‐219 expression underlies cellular pathogenesis of oligodendrocytes in a mouse model of Krabbe disease7
Human amygdala involvement in Alzheimer's disease revealed by stereological and dia‐PASEF analysis7
Primary age‐related tauopathy (PART) in the general autopsy setting: Not just a disease of the elderly7
An early proinflammatory transcriptional response to tau pathology is age‐specific and foreshadows reduced tau burden7
Iron accumulation in the choroid plexus, ependymal cells and CNS parenchyma in a rat strain with low‐grade haemolysis of fragile macrocytic red blood cells7
Variable histopathology features of neuronal dyslamination in the cerebral neocortex adjacent to epilepsy‐associated vascular malformations suggest complex pathogenesis of focal cortical dysplasia ILA7
A comprehensive analysis of infantile central nervous system tumors to improve distinctive criteria for infant‐type hemispheric glioma versus desmoplastic infantile ganglioglioma/astrocytoma6
Progression of phosphorylated α‐synuclein in Macaca fuscata6
Antenatal low‐intensity pulsed ultrasound reduces neurobehavioral deficits and brain injury following dexamethasone‐induced intrauterine growth restriction6
Concurrent cardiac transthyretin and brain β amyloid accumulation among the older adults: The Hisayama study6
Dendritic spine loss in epileptogenic Type II focal cortical dysplasia: Role of enhanced classical complement pathway activation6
Histamine in murine narcolepsy: What do genetic and immune models tell us?6
Differential perivascular microglial activation in the deep white matter in vascular dementia developed post‐stroke6
Lumbar spine intrathecal transplantation of neural precursor cells promotes oligodendrocyte proliferation in hot spots of chronic demyelination6
Distinct and dementia‐related synaptopathy in the hippocampus after military blast exposures6
Hispano‐American Brain Bank on Neurodevelopmental Disorders: An initiative to promote brain banking, research, education, and outreach in the field of neurodevelopmental disorders6
Evidence of beta amyloid independent small vessel disease in familial Alzheimer's disease6
The presence of TIM‐3 positive cells in WHO grade III and IV astrocytic gliomas correlates with isocitrate dehydrogenase mutation status6
Leigh syndrome is the main clinical characteristic of PTCD3 deficiency6
Lipid metabolism and oxidative stress in patients with Alzheimer's disease and amnestic mild cognitive impairment6
Deciphering the genetic and epigenetic landscape of pediatric bithalamic tumors6
Microvessel stenosis, enlarged perivascular spaces, and fibrinogen deposition are associated with ischemic periventricular white matter hyperintensities6
Information theory approaches to improve glioma diagnostic workflows in surgical neuropathology6
A new amplicon‐based gene panel for next generation sequencing characterization of meningiomas6
Enhanced expression of autophagy‐related p62 without increased deposits of neurodegeneration‐associated proteins in glioblastoma and surrounding tissue – An autopsy‐based study5
Inflammatory and oxidative stress markers in intracerebral hemorrhage: Relevance as prognostic markers for quantification of the edema volume5
Peripheral macrophages drive CNS disease in the Ndufs4(−/−) model of Leigh syndrome5
Role of VAPB and vesicular profiles in α‐synuclein aggregates in multiple system atrophy5
Innate immune activation without immune cell infiltration in brains of murine models of Aicardi‐Goutières Syndrome5
Quantitative magnetic resonance imaging reflects different levels of histologically determined myelin densities in multiple sclerosis, including remyelination in inactive multiple sclerosis lesions5
No evidence of aberrant amyloid β and phosphorylated tau expression in herpes simplex virus‐infected neurons of the trigeminal ganglia and brain5
AtypicalTDP‐43 protein expression in anALSpedigree carrying a p.Y374Xtruncation mutation inTARDBP5
Vascular endothelial growth factor‐C modulates cortical NMDA receptor activity in cortical lesions of young patients and rat model with focal cortical dysplasia5
Transcriptome analysis following neurotropic virus infection reveals faulty innate immunity and delayed antigen presentation in mice susceptible to virus‐induced demyelination5
Cerebellar developmental deficits underlie neurodegenerative disorder spinocerebellar ataxia type 235
Fra‐1 induces apoptosis and neuroinflammation by targeting S100A8 to modulate TLR4 pathways in spinal cord ischemia/reperfusion injury5
Exploiting nanopore sequencing for characterization and grading of IDH‐mutant gliomas5
Differential expression of checkpoint markers in the normoxic and hypoxic microenvironment of glioblastomas4
Report two adult cases of high‐grade neuroepithelial neoplasm harbouring EP300::BCOR fusions with comprehensive molecular detection4
Different modes of synaptic and extrasynaptic NMDA receptor alteration in the hippocampus of P301S tau transgenic mice4
Serpin neuropathology in the P497S UBQLN2 mouse model of ALS/FTD4
Inorganic phosphate exporter heterozygosity in mice leads to brain vascular calcification, microangiopathy, and microgliosis4
Brachial plexus lipomatosis with perineurial pseudoonion bulb formation: Result of a mosaic PIK3CA mutation in the para‐axial mesoderm state4
The molecular spectrum of amyloid‐beta (Aβ) in neurodegenerative diseases beyond Alzheimer's disease4
Temporal lobe myxoid glioneuronal tumor, PDGFRA p.K385L‐mutant with DNA methylation confirmation4
Proteomic analysis identifies HSP90AA1, PTK2B, and ANXA2 in the human entorhinal cortex in Alzheimer's disease: Potential role in synaptic homeos4
Early and extensive alterations of glial connexins, distal oligodendrogliopathy type demyelination, and nodal/paranodal pathology are characteristic of multiple system atrophy4
Expression pattern of mitochondrial respiratory chain enzymes in skeletal muscle of patients with mitochondrial myopathy associated with the homoplasmic m.14674T>C variant4
Double‐edged effects of tamoxifen‐in‐oil‐gavage on an infectious murine model for multiple sclerosis4
Attenuation of Piwil2 induced by hypoxic postconditioning prevents cerebral ischemic injury by inhibiting CREB2 promoter methylation4
Cerebellar structural, astrocytic, and neuronal abnormalities in the SMNΔ7 mouse model of spinal muscular atrophy4
Studying the imaging features and infarction mechanism of vertebrobasilar dolichoectasia with high‐resolution magnetic resonance imaging4
Krüppel‐like factor 7 deficiency disrupts corpus callosum development and neuronal migration in the developing mouse cerebral cortex3
Present and future avenues of cell‐based therapy for brain injury: The enteric nervous system as a potential cell source3
Tumor‐associated astrocytes promote tumor progression of Sonic Hedgehog medulloblastoma by secreting lipocalin‐23
Mic60 is essential to maintain mitochondrial integrity and to prevent encephalomyopathy3
An H3F3A K27M‐mutation in a sonic hedgehog medulloblastoma3
Targeting autotaxin impacts disease advance in the SOD1‐G93A mouse model of amyotrophic lateral sclerosis3
Cortical iron accumulation in MAPT‐ and C9orf 72‐associated frontotemporal lobar degeneration3
Plasma mid‐regional pro‐adrenomedullin: A biomarker of the ischemic penumbra in hyperacute stroke3
Detection and verification of neurodegeneration after traumatic brain injury in the mouse: Immunohistochemical staining for amyloid precursor protein3
Myelin protein zero mutation‐related hereditary neuropathies: Neuropathological insight from a new nerve biopsy cohort3
A 2‐year‐old girl with posterior fossa mass3
3
Announcing the Asian Oceanian Society of Neuropathology guidelines for Adapting Diagnostic Approaches for Practical Taxonomy in Resource‐Restrained Regions (AOSNP‐ADAPTR)3
The WHO classification of tumors of the central nervous system‐finally here, and welcome!3
Pathology explains various mechanisms of auto‐immune inflammatory peripheral neuropathies3
Distinct Aβ pathology in the olfactory bulb and olfactory deficits in a mouse model of Aβ and α‐syn co‐pathology2
Decreased DHA‐containing phospholipids in the neocortex of dementia with Lewy bodies are associated with soluble Aβ42, phosphorylated α‐synuclein, and synaptopathology2
Special Issue: Abstracts of the 20th International Congress of Neuropathology, Berlin, Germany, September 13–16, 20232
Induced pluripotent stem cell models as a tool to investigate and test fluid biomarkers in Alzheimer's disease and frontotemporal dementia2
RNA‐sequencing highlights differential regulated pathways involved in cell cycle and inflammation in orbitofacial neurofibromas2
A 7‐year‐old female with hypotonia and scoliosis2
Loss of fidelity in scanned digital images compared to glass slides of brain tumors resected using cavitron ultrasonic surgical aspirator2
Dynamic induction of the myelin‐associated growth inhibitor Nogo‐A in perilesional plasticity regions after human spinal cord injury2
Clinical, neuropathological, and immunological short‐ and long‐term feature of a mouse model mimicking human herpes virus encephalitis2
Diagnostic utility of genetic alterations in distinguishing IDH‐wildtype glioblastoma from lower‐grade gliomas: Insight from next‐generation sequencing analysis of 479 cases2
Contribution of whole slide imaging‐based deep learning in the assessment of intraoperative and postoperative sections in neuropathology2
LATE‐NC in Alzheimer's disease: Molecular aspects and synergies2
Distribution of ubiquilin 2 and TDP‐43 aggregates throughout the CNS in UBQLN2 p.T487I‐linked amyotrophic lateral sclerosis and frontotemporal dement2
Design and application of a customizable relational DataBase to assess clinicopathological correlations and concomitant pathology in neurodegenerative diseases2
Severe histomorphological alterations in post‐mortem olfactory glomeruli in Alzheimer’s disease2
The relation between BTK expression and iron accumulation of myeloid cells in multiple sclerosis2
Refinement of prognostication for IDH‐mutant astrocytomas using DNA methylation‐based classification2
Colocalization of TDP‐43 and stress granules at the early stage of TDP‐43 aggregation in amyotrophic lateral sclerosis2
The myeloid side of the CNS2
Reduced neurogenesis in human hippocampus with Alzheimer's disease2
SPI1 activates TGF‐β1/PI3K/Akt signaling through transcriptional upregulation of FKBP12 to support the mesenchymal phenotype of glioma stem cells2
An 82‐year‐old man with a right frontal lobe rim‐enhancing lesion2
Developmental delay and progressive seizures in 2‐month‐old child with diffuse MRI abnormalities2
An elderly man with bilateral cavitary lesions in the globus pallidus1
Alleviating early demyelination in ischaemia/reperfusion by inhibiting sphingosine‐1‐phosphate receptor 2 could protect visual function from impairment1
Transient receptor potential vanilloid 1 inhibition reduces brain damage by suppressing neuronal apoptosis after intracerebral hemorrhage1
The pontine diffuse midline glioma, EGFR‐subtype with ependymal features: Yet another face of diffuse midline glioma, H3K27‐altered1
Distribution of ferritin complex in the adult brain and altered composition in neuroferritinopathy due to a novel variant in the ferritin heavy chain gene FTH1 (c.409_410del; p.1
A vade mecum for crossing the second translational “valley of death” in brain tumor classification1
Single‐nucleus RNA sequencing unveils critical regulators in various hippocampal neurons for anti‐N‐methyl‐D‐aspartate receptor encephalitis1
Neuropathological stage‐dependent proteome mapping of the olfactory tract in Alzheimer's disease: From early olfactory‐related omics signatures to computational repurposing of drug candidat1
A role for vessel‐associated extracellular matrix proteins in multiple sclerosis pathology1
Recent data and developments in myositis1
Did early studies of human traumatic brain injury overlook concomitant oligodendrocyte pathology in injured white matter tracts? A comment on “Detection and verification of neurodegeneration after tra1
NAB2::STAT6 fusions and genome‐wide DNA methylation profiling: Predictors of patient outcomes in meningeal solitary fibrous tumors1
1
1
Low‐grade BRAF V600E mutant oligodendroglioma‐like tumors of children may show EGFR and MET amplification1
Understanding the pathogenic mechanisms and therapeutic effects in neurocysticercosis1
Astrocytes for brain repair: More than just a neuron’s sidekick1
41‐year‐old male with a pituitary mass1
72‐year‐old man with right homonymous hemianopia and gait instability1
Enhanced Creutzfeldt‐Jakob disease surveillance in the older population: Assessment of a protocol for screening brain tissue donations for prion disease1
Introduction to the mini‐symposium “molecular neuropathology of meningioma”1
Multiple system atrophy with hippocampal pathology1
Gliovascular alterations in sporadic and familial Alzheimer's disease: APOE3 Christchurch homozygote glioprotection1
Age‐related hearing loss and dementia‐related neuropathology: An analysis of the United Kingdom brains for dementia research cohort1
A tribute to John Q. Trojanowski (1946–2022), neuropathologist extraordinaire1
Alzheimer's disease phenotype based upon the carrier status of the apolipoprotein E ɛ4 allele1
Supratentorial tumor resembling anaplastic ependymoma in an adolescent1
Friends or foes: The mononuclear phagocyte system in ischemic stroke1
Two novel tumours with NTRK2 fusion in the methylation class of extraventricular neurocytomas, including one intraventricular1
Epilepsy‐associated death in the Southwestern Ontario: A clinicopathological correlation study1
IFNγ protects motor neurons from oxidative stress via enhanced global protein synthesis in FUS‐associated amyotrophic lateral sclerosis1
Brain Pathology moves to open access1
Molecular landscapes of longitudinal NF2/22q and non‐NF2/22q meningiomas show different life histories1
Huntingtin CAG repeats in neuropathologically confirmed tauopathies: Novel insights1
A 4‐year‐old boy with a ventricular mass1
DNA methylation profiling of central nervous system hemangioblastomas identifies two distinct subgroups1
Dysregulation of the renin‐angiotensin system in vascular dementia1
A diffuse glioma with oligodendroglial‐like cells and extensive calcifications1
Correspondence comprehensive characterization of a brainstem aggregoma (light and heavy chain deposition disease)1
0.058151960372925